Mondrian Investment Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18M Sell
4,415
-112,750
-96% -$30.5M 0.02% 58
2025
Q4
$29.4M Sell
117,165
-144,829
-55% -$38.5M 0.49% 47
2025
Q3
$75.2M Buy
+261,994
New +$70.2M 1.26% 41
2025
Q1
$62.9M Sell
270,068
-143,382
-35% -$34.8M 1.08% 41
2024
Q4
$103M Sell
413,450
-83,588
-17% -$19.2M 1.71% 31
2024
Q3
$111M Sell
497,038
-64,717
-12% -$14.2M 1.68% 33
2024
Q2
$121M Sell
561,755
-29,301
-5% -$5.96M 1.86% 27
2024
Q1
$129M Buy
591,056
+5,510
+0.9% +$1.21M 1.77% 23
2023
Q4
$133M Buy
585,546
+8,137
+1% +$1.71M 2.1% 19
2023
Q3
$116M Sell
577,409
-185,548
-24% -$39.1M 2.39% 13
2023
Q2
$158M Buy
762,957
+42,644
+6% +$8.27M 3.16% 7
2023
Q1
$142M Buy
720,313
+103,522
+17% +$21.3M 3.13% 9
2022
Q4
$125M Buy
616,791
+943
+0.2% +$184K 2.76% 14
2022
Q3
$108K Buy
615,848
+75,004
+14% +$15.4M 2.37% 16
2022
Q2
$109M Buy
+540,844
New +$115M 2.27% 17

Other funds holding LH

Mondrian Investment Partners's LH Position: Q1 2026 in Review

Mondrian Investment Partners reduced its Labcorp (LH) stake by 96% in Q1 2026, selling an estimated $30.5M and leaving 4,415 shares worth $1.18M. The position accounts for 0.02% of the portfolio, ranked #58.

Mondrian Investment Partners first reported a position in LH in Q2 2022 and has held it in 15 quarters since. The position peaked at $158M in Q2 2023. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Mondrian Investment Partners held 4,415 shares of Labcorp worth $1.18M as of Q1 2026.
  • Mondrian Investment Partners sold 112,750 Labcorp shares in Q1 2026, an estimated $30.5M.
  • Labcorp made up 0.02% of Mondrian Investment Partners's portfolio in Q1 2026, its #58 holding.
  • Mondrian Investment Partners first reported a position in Labcorp in Q2 2022 and has held it in 15 quarters since.
  • Mondrian Investment Partners's Labcorp position peaked at $158M in Q2 2023.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Mondrian Investment Partners's 13F filing for Q1 2026, filed 29 Apr 2026.